Phillip E. Lee - Dec 8, 2023 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Chief Financial Officer
Signature
/s/ Edward Berg, Attorney-in-Fact
Stock symbol
VXRT
Transactions as of
Dec 8, 2023
Transactions value $
-$28,701
Form type
4
Date filed
3/20/2024, 08:10 PM
Previous filing
Jun 14, 2023
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Tax liability -$25K -35.2K -18.22% $0.71 158K Dec 8, 2023 Direct F1, F2
transaction VXRT Common Stock Tax liability -$3.74K -5.94K -3.77% $0.63* 152K Dec 15, 2023 Direct F1, F3
transaction VXRT Common Stock Award $0 +90K +59.29% $0.00 242K Mar 18, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +410K $0.00 410K Mar 18, 2024 Common Stock 410K $1.16 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to administrative oversight.
F2 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023.
F3 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 15, 2023.
F4 Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
F5 The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028.